22:21:45 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-11-29 Kvartalsrapport 2024-Q3
2024-08-30 Kvartalsrapport 2024-Q2
2024-05-31 Kvartalsrapport 2024-Q1
2024-05-29 Ordinarie utdelning POLAR 0.00 SEK
2024-05-28 Årsstämma 2024
2024-02-23 Bokslutskommuniké 2023
2023-11-24 Kvartalsrapport 2023-Q3
2023-09-08 Extra Bolagsstämma 2023
2023-08-25 Kvartalsrapport 2023-Q2
2023-05-26 Kvartalsrapport 2023-Q1
2023-05-17 Årsstämma 2023
2023-05-05 Ordinarie utdelning POLAR 0.00 SEK
2023-03-13 Extra Bolagsstämma 2022
2023-02-24 Bokslutskommuniké 2022
2022-11-25 Kvartalsrapport 2022-Q3
2022-08-26 Kvartalsrapport 2022-Q2
2022-05-27 Kvartalsrapport 2022-Q1
2022-05-06 Ordinarie utdelning POLAR 0.00 SEK
2022-05-05 Årsstämma 2022
2022-02-25 Bokslutskommuniké 2021
2021-11-26 Kvartalsrapport 2021-Q3
2021-08-27 Kvartalsrapport 2021-Q2
2021-05-28 Kvartalsrapport 2021-Q1
2021-05-06 Ordinarie utdelning POLAR 0.00 SEK
2021-05-05 Årsstämma 2021
2021-02-26 Bokslutskommuniké 2020
2020-11-27 Kvartalsrapport 2020-Q3
2020-08-28 Kvartalsrapport 2020-Q2
2020-07-01 Ordinarie utdelning POLAR 0.00 SEK
2020-06-30 Årsstämma 2020
2020-05-29 Kvartalsrapport 2020-Q1
2020-02-28 Bokslutskommuniké 2019
2020-02-14 Extra Bolagsstämma 2020
2019-10-23 Kvartalsrapport 2019-Q3
2019-07-24 Kvartalsrapport 2019-Q2
2019-05-07 Split POLAR 16:1
2019-04-26 Kvartalsrapport 2019-Q1
2019-03-19 Årsstämma 2019
2019-02-04 Ordinarie utdelning POLAR 0.00 SEK
2019-02-01 Bokslutskommuniké 2018

Beskrivning

LandSverige
ListaSpotlight
SektorHälsovård
IndustriMedicinteknik
Polarcool är verksamt inom medicinteknik. Idag är bolaget inriktade mot att produkter och lösningar inriktade för skador inom sport och aktivitet. Störst fokus återfinns inom forskning och utveckling av produkter som används vid behandling av hjärnskador vid exempelvis boxning, rugby och amerikansk fotboll. Verksamhet innehas på global nivå, med störst närvaro inom den europeiska marknaden.
2024-02-13 10:16:00

The med-tec company PolarCool's concussion treatment product, PolarCap®, has been recognized by being shortlisted in the medical category of the Sports Technology Awards, the premier platform highlighting and celebrating technological advancements in sports. PolarCap® is shortlisted in the category of Sports and Exercise Medical.

PolarCool develops and markets the product PolarCap®, which alleviates the effects of concussions. The primary users of PolarCap® include sports clubs, organizations, and facilities in contact sports such as ice hockey, rugby, football, and handball, but also other sports with an increased risk of concussion.

The Sports Technology Awards (http://www.sportstechgroup.org/sports-technology-awards), renowned as the pinnacle of global recognition for tech-driven progress in sports, has singled out PolarCool for consideration in the Sports and Exercise Medical Category. This category honors advancements in medical and scientific technology geared towards monitoring, diagnosing, treating, and rehabilitating athletes across all levels. Areas of focus include biomechanics, injury assessment and prevention, medical diagnostic imaging, prosthetics and assistive devices, rehabilitation, sports nutrition, and physiology, as well as telemedicine and remote monitoring.

With entries spanning across 5 continents, representing over 30 countries, and encompassing more than 50 sports, the Sports Technology Awards receive significant attention from the global sports community. The annual cycle commences with entries opening in September, followed by a shortlisting process conducted by over 50 industry experts who review all submissions. The 2024 Awards ceremony is set to take place in London, where the most outstanding innovations in sports technology are celebrated and honored.

This global recognition and exposure of PolarCap® being shortlisted among world-leading sports technology brands is very impactful and highlights the treatment on the global stage. This recognition confirms PolarCool's role as a pioneer and a game-changer in athletes' concussion recovery.

PolarCool's CEO Erik Andersson comments:

-I am very proud of PolarCool being shortlisted by the Sport Technology Awards. The dedication and hard work behind the innovation resulting in PolarCap® is impressive. This nomination reaffirms our commitment to advancing the treatment of concussions with PolarCap® to the benefit of athletes worldwide. We are honored to be considered among the leaders in the Sports and Exercise Medical Category.